Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM.
Here's what investors need to know about the announcement.
Earnings
Biohaven Pharma Hldgs beat estimated earnings by 35.97%, reporting an EPS of $-1.62 versus an estimate of $-2.53.
Revenue was up $275.03 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.28 which was followed by a 8.87% drop in the share price the next day.
Here's a look at Biohaven Pharma Hldgs's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -2.04 | -2.40 | -2.74 | -2.82 |
| EPS Actual | -2.32 | -1.91 | -2.62 | -2.97 |
| Revenue Estimate | 173.69M | 128.40M | 78.13M | 40.63M |
| Revenue Actual | 190.01M | 135.74M | 92.93M | 43.82M |
To track all earnings releases for Biohaven Pharma Hldgs visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
